Informações:
Falhas:
Palavras-chave
PISHCHEVOD ×
- Clinical Trial (11)
- Adenocarcinoma (9)
- Treatment Form (3)
- Follow-Up Studies (3)
- Registration (2)
- Routine documentation (2)
- Quality of Life (1)
- Barrett Esophagus (1)
- On-Study Form (1)
- Disease Response (1)
- Diagnostic Imaging (1)
- Hypopharynx (1)
- Medical Oncology (1)
- Neoplasms (1)
Índice
Modelos de dados selecionados
Deve ter sessão iniciada para selecionar vários modelos de dados e para os transferir ou analisar.
13 Resultados da pesquisa.
Grupos de itens: Header Module, Header, Disease Extent, Other Tumor Involvement, BASELINE LABS, EXAMINATIONS / CONSULTATIONS, General Conditions, Footer Module
Grupos de itens: Header Module, Unnamed 1, Footer Module
Grupos de itens: RTOG clinical trial administrative data, Patient status, Disease Assessment, Disease Events, New Primary, Protocol Specific Adverse Events Evaluation, REPORT ALL CONTINUING OR NEW ADVERSE EVENTS, Footer
Grupos de itens: Header Module, EQ-5D Cover Sheet, EQ-5D Health State Measurement, Health State
Grupo de itens: Colon CA
Grupo de itens: Hypopharynx- Esophagram findings
Grupos de itens: Header Module, Summary Of Maintenance Systemic Treatment, Treatment Summary, Therapy Modification, LVEF/ Other Toxicities, Adverse Events, Comments
Grupos de itens: RTOG clinical trial administrative data, Summary of Concurrent Treatment, Treatment Summary, Therapy Modification, Toxicities, PROTOCOL SPECIFIC ADVERSE EVENT EVALUATION, PROTOCOL SPECIFIC ADVERSE EVENT EVALUATION DAY 8, PROTOCOL SPECIFIC ADVERSE EVENT EVALUATION DAY 15, PROTOCOL SPECIFIC ADVERSE EVENT EVALUATION DAY 22, PROTOCOL SPECIFIC ADVERSE EVENT EVALUATION DAY 29, Adverse Events, Comments
Grupos de itens: Header Module, Header, Current Disease Status, Events, New Primary Cancer, Additional Non Protocol Treatment, Toxicities, Adverse Events, Footer Module
Grupos de itens: Header Module, Header, Current Disease Status, Events, Toxicities, LVEF Status, Adverse Events, Footer Module
Grupos de itens: Protocol Information, SWOG PATIENT ID, DEMOGRAPHY, FOR SWOG INSTITUTIONS, PATIENT INFORMATION, Indicate how the patient answered the following questions on the consent form, Patient Eligibility
Grupos de itens: Protocol Administration, Pre-Treatment Characteristics, Certification Of Eligibility, Protocol Design (Stratification Factors), Companion Studies - Study 151007: Molecular Markers of Treatment Response (optional), Companion Studies - Study 71003: Correlation of QOL with Treatment Response and Validation of PRO-CTCAE (optional)